Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2006 1
2010 2
2011 1
2014 1
2017 1
2019 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Current thinking on the management of abnormal retropharyngeal nodes in patients with oral, oropharyngeal, and nasopharyngeal squamous cell carcinoma: a structured review.
Doumas S, Fort-Schaale A, Skoulakis C, Moor J, Kanatas A. Doumas S, et al. Br J Oral Maxillofac Surg. 2019 Jul;57(6):515-528. doi: 10.1016/j.bjoms.2019.04.017. Epub 2019 May 7. Br J Oral Maxillofac Surg. 2019. PMID: 31076218 Free article. Review.
The management of enlarged retropharyngeal lymph nodes (RLN) in patients with confirmed oral, oropharyngeal, or nasopharyngeal squamous cell carcinoma (SCC) has prognostic relevance and is a challenge for the clinical teams. ...There was no cons …
The management of enlarged retropharyngeal lymph nodes (RLN) in patients with confirmed oral, oropharyngeal, or nasopharyngeal squ …
Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region.
Psyrri A, Fountzilas G. Psyrri A, et al. Med Oncol. 2006;23(1):1-15. doi: 10.1385/MO:23:1:1. Med Oncol. 2006. PMID: 16645225 Review.
Traditionally, chemotherapy has been incorporated in the treatment of SCCHN either before local treatment as induction, concomitantly with radiation, or following local treatment as adjuvant therapy. A number of randomized trials and meta-analyses have demonstrated that in …
Traditionally, chemotherapy has been incorporated in the treatment of SCCHN either before local treatment as induction, concomitantly with r …
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM, Yao M, Yao J, Wang J, Cheng Y, Schrock AB, Chirn GW, Chen H, Mu S, Gay L, Elvin JA, Suh J, Miller VA, Stephens PJ, Ross JS, Wang K. Ali SM, et al. Cancer. 2017 Sep 15;123(18):3628-3637. doi: 10.1002/cncr.30781. Epub 2017 Jun 5. Cancer. 2017. PMID: 28581676 Free article.
METHODS: Comprehensive genomic profiling was performed for 190 NPC patients, including 20 patients with nasopharyngeal adenocarcinoma (NPAC), 62 patients with nasopharyngeal squamous cell carcinoma (NPSCC), and 108 patients with nasopharyngeal undiffer …
METHODS: Comprehensive genomic profiling was performed for 190 NPC patients, including 20 patients with nasopharyngeal adenocarcinoma (NPAC) …
Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma.
Omura G, Honma Y, Matsumoto Y, Shinozaki T, Itoyama M, Eguchi K, Sakai T, Yokoyama K, Watanabe T, Ohara A, Kato K, Yoshimoto S. Omura G, et al. Auris Nasus Larynx. 2023 Aug;50(4):641-645. doi: 10.1016/j.anl.2022.06.004. Epub 2022 Jun 29. Auris Nasus Larynx. 2023. PMID: 35779979
HNC-PIT has been conditionally approved in Japan in September 2020 for the treatment of unresectable locally advanced or unresectable locoregionally recurrent HNC. However, its outcomes on the local recurrence of the nasopharyngeal squamous cell carcinoma …
HNC-PIT has been conditionally approved in Japan in September 2020 for the treatment of unresectable locally advanced or unresectable locore …
Potential of unglycosylated horseradish peroxidase variants for enzyme prodrug cancer therapy.
Humer D, Furlanetto V, Schruef AK, Wlodarczyk A, Kuttke M, Divne C, Spadiut O. Humer D, et al. Biomed Pharmacother. 2021 Oct;142:112037. doi: 10.1016/j.biopha.2021.112037. Epub 2021 Aug 13. Biomed Pharmacother. 2021. PMID: 34392084 Free article.
In this study, we generated recombinant, unglycosylated HRP variants in Escherichia coli using random mutagenesis and investigated their biochemical properties and suitability for cancer treatment. The cytotoxicity of the HRP-IAA enzyme prodrug system was assessed in vitro …
In this study, we generated recombinant, unglycosylated HRP variants in Escherichia coli using random mutagenesis and investigated th …
Improved survival of patients with nasopharyngeal squamous cell carcinoma.
Yamashita S, Kondo M, Inuyama Y, Hashimoto S. Yamashita S, et al. Int J Radiat Oncol Biol Phys. 1986 Mar;12(3):307-12. doi: 10.1016/0360-3016(86)90343-3. Int J Radiat Oncol Biol Phys. 1986. PMID: 3957731
One hundred and one patients with nasopharyngeal squamous cell carcinoma (NPC) were treated with irradiation. ...
One hundred and one patients with nasopharyngeal squamous cell carcinoma (NPC) were treated with irradiation. .. …
Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience.
Osman N, Elamin YY, Rafee S, O'Brien C, Stassen LF, Timon C, Kinsella J, Brennan S, O'Byrne KJ. Osman N, et al. Eur Arch Otorhinolaryngol. 2014 Aug;271(8):2253-9. doi: 10.1007/s00405-013-2749-9. Eur Arch Otorhinolaryngol. 2014. PMID: 24121822
Included patients had squamous cell carcinoma arising in the oral cavity, oropharynx, larynx, or hypopharynx. Patients were excluded if they had nasopharyngeal squamous cell carcinoma, distant metastasis or if they had prior treatment for head and neck …
Included patients had squamous cell carcinoma arising in the oral cavity, oropharynx, larynx, or hypopharynx. Patients were excluded if they …
4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells.
Kim SG, Jeong JH, Park YW, Song JY, Kim AS, Choi JY, Chae WS. Kim SG, et al. Oncol Rep. 2011 Jun;25(6):1597-602. doi: 10.3892/or.2011.1218. Epub 2011 Mar 17. Oncol Rep. 2011. PMID: 21424127
The objective of this study was to demonstrate the effect of 4-hexylresorcinol (4-HR) on TG-2 activity in nasopharyngeal squamous cell carcinoma cells (KB cells). Treatment with a mixture of 4-HR and cisplatin significantly decreased KB cell viability …
The objective of this study was to demonstrate the effect of 4-hexylresorcinol (4-HR) on TG-2 activity in nasopharyngeal squamous …
In vivo characterization of horseradish peroxidase with indole-3-acetic acid and 5-bromoindole-3-acetic acid for gene therapy of cancer.
Tupper J, Stratford MR, Hill S, Tozer GM, Dachs GU. Tupper J, et al. Cancer Gene Ther. 2010 Jun;17(6):420-8. doi: 10.1038/cgt.2009.86. Epub 2010 Jan 15. Cancer Gene Ther. 2010. PMID: 20075982
This study characterized HRP-directed gene therapy in vivo. Human nasopharyngeal squamous cell carcinoma cells, FaDu, stably expressing HRP were grown as xenografts in SCID mice. ...
This study characterized HRP-directed gene therapy in vivo. Human nasopharyngeal squamous cell carcinoma cells, …
Ocular ischemic syndrome secondary to carotid artery occlusion as a late complication of radiotherapy of nasopharyngeal carcinoma.
Tang Y, Luo D, Peng W, Huang F, Peng Y. Tang Y, et al. J Neuroophthalmol. 2010 Dec;30(4):315-20. doi: 10.1097/WNO.0b013e3181dee914. J Neuroophthalmol. 2010. PMID: 20736842
A 39-year-old Chinese man developed ocular ischemic syndrome (OIS) in both eyes 14 years after radiation therapy for nasopharyngeal squamous cell carcinoma. Digital subtraction angiography disclosed occlusion of common carotid arteries and stenosis of …
A 39-year-old Chinese man developed ocular ischemic syndrome (OIS) in both eyes 14 years after radiation therapy for nasopharyngeal …